\-\ Texto\\:\\ \ \(0\)\
\-\ large\\ cutaneous\\ hairy\\ nevi\\ demonstrated\\ on\\ bilateral\\ chest\\ walls\\.\ \(0\)\
\-\ csf\\ cytology\\:\\ \\ atypical\\ cells\\ with\\ melanini\\ pigment\\ consistent\\ with\\ malignant\\ melanoma\\.\ \(0\)\
\-\ patient\\ is\\ undergoing\\ chemotherapy\\ with\\ temozolamide\\ and\\ cns\\ radiation\\ therapy\\.\ \(0\)\
\-\ mr\\ of\\ the\\ the\\ spine\\ demonstrates\\ a\\ linear\\ focus\\ of\\ abnormal\\ t2\\ signal\\ in\\ the\\ intrathecal\\ space\\ from\\ t7\\ to\\ t8\\ with\\ adjacent\\ thickening\\ of\\ the\\ dura\\ superior\\ and\\ inferiorly\\.\\ \\ \ \(0\)\
\-\ mr\\ of\\ the\\ brain\\ demonstrates\\ leptomeningeal\\ enhancement\\ with\\ no\\ focal\\ parenchymal\\ enhancement\\.\\ \\ nonenhancing\\ lesions\\ that\\ are\\ hyperintense\\ on\\ t1wi\\ in\\ the\\ bilateral\\ temporal\\ lobes\\.\\ \\ \ \(0\)\
\-\ fdg\\ pet\\ imaging\\ demonstrated\\ low\\ grade\\ activity\\ in\\ the\\ thorac\\ spinal\\ cord\\ with\\ a\\ standard\\ uptake\\ value\\ \\(suv\\)\\ of\\ 2\\.0\\.\ \(0\)\
\-\ neurocutaneous\\ melanosis\ \(0\)\
\-\ neurocutaneous\\ melanosis\ \(0\)\
\-\ malignant\\ melanoma\ \(7\)\
\-\ 14\\ year\\ old\\ with\\ new\\ onset\\ diabetes\\ with\\ transient\\ peripheral\\ seventh\\ and\\ sixth\\ nerve\\ palsies\\.\ \(1\)\
\-\ the\\ radiographic\\ findings\\ in\\ this\\ adolescent\\ patient\\ have\\ been\\ described\\ in\\ case\\ reports\\ as\\ having\\ increased\\ signal\\ in\\ the\\ temporal\\ lobes\\,\\ leptomeningeal\\ enhancement\\ and\\ associated\\ intraspinal\\ lesion\\.\\ \\ this\\ is\\ a\\ rare\\ condition\\ that\\ is\\ typically\\ fatal\\ in\\ early\\ infancy\\ from\\ complications\\ from\\ mass\\ effect\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ melanosis\\:\\ 0\\.27121870006243626\ \(0\)\
\-\ neurocutaneous\\:\\ 0\\.24485623745496712\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.18766079716478293\ \(0\)\
\-\ melanoma\\:\\ 0\\.16574294324342354\ \(0\)\
\-\ the\\:\\ 0\\.1593644222634278\ \(0\)\
\-\ in\\:\\ 0\\.15453215193686562\ \(0\)\
\-\ enhancement\\:\\ 0\\.15323430254314233\ \(0\)\
\-\ lobes\\:\\ 0\\.14808258645314468\ \(0\)\
\-\ melanini\\:\\ 0\\.14191708385828702\ \(0\)\
\-\ temozolamide\\:\\ 0\\.14191708385828702\ \(0\)\
\-\ with\\:\\ 0\\.13901366516519606\ \(0\)\
\-\ temporal\\:\\ 0\\.1363379537499936\ \(0\)\
\-\ hairy\\:\\ 0\\.13560935003121813\ \(0\)\
\-\ nevi\\:\\ 0\\.13560935003121813\ \(0\)\
\-\ malignant\\:\\ 0\\.12651630205271708\ \(0\)\
\-\ thorac\\:\\ 0\\.12482620783100433\ \(0\)\
\-\ palsies\\:\\ 0\\.11851847400393543\ \(0\)\
\-\ intrathecal\\:\\ 0\\.11539668298281906\ \(0\)\
\-\ mr\\:\\ 0\\.11483967718332007\ \(0\)\
\-\ pigment\\:\\ 0\\.11279785837446636\ \(0\)\
\-\ adolescent\\:\\ 0\\.11279785837446636\ \(0\)\
\-\ t8\\:\\ 0\\.11164497652726976\ \(0\)\
\-\ infancy\\:\\ 0\\.11164497652726976\ \(0\)\
\-\ t7\\:\\ 0\\.11057166920537619\ \(0\)\
\-\ seventh\\:\\ 0\\.10956765725764563\ \(0\)\
\-\ demonstrated\\:\\ 0\\.10907635826184274\ \(0\)\
\-\ intraspinal\\:\\ 0\\.10773533180372163\ \(0\)\
\-\ from\\:\\ 0\\.10573316383398645\ \(0\)\
\-\ suv\\:\\ 0\\.10533724270020087\ \(0\)\
\-\ cytology\\:\\ 0\\.10461354078260526\ \(0\)\
\-\ nonenhancing\\:\\ 0\\.10392201423486078\ \(0\)\
\-\ fatal\\:\\ 0\\.10392201423486078\ \(0\)\
\-\ sixth\\:\\ 0\\.10262486440681694\ \(0\)\
\-\ signal\\:\\ 0\\.10061014198192289\ \(0\)\
\-\ t1wi\\:\\ 0\\.09695218960350785\ \(0\)\
\-\ dura\\:\\ 0\\.0965259496315415\ \(0\)\
\-\ fdg\\:\\ 0\\.09611107742462423\ \(0\)\
\-\ bilateral\\:\\ 0\\.09538598492842354\ \(0\)\
\-\ cutaneous\\:\\ 0\\.09215601139646629\ \(0\)\
\-\ value\\:\\ 0\\.09035900215697712\ \(0\)\
\-\ demonstrates\\:\\ 0\\.08916559600806603\ \(0\)\
\-\ transient\\:\\ 0\\.08728872371861486\ \(0\)\
\-\ of\\:\\ 0\\.08683165883278579\ \(0\)\
\-\ inferiorly\\:\\ 0\\.08512457565180179\ \(0\)\
\-\ walls\\:\\ 0\\.08322505015482139\ \(0\)\
\-\ cns\\:\\ 0\\.08287147162171177\ \(0\)\
\-\ standard\\:\\ 0\\.08235572983443318\ \(0\)\
\-\ pet\\:\\ 0\\.08218754672854192\ \(0\)\
\-\ diabetes\\:\\ 0\\.08105858000638934\ \(0\)\
\-\ undergoing\\:\\ 0\\.08059874005207966\ \(0\)\
\-\ parenchymal\\:\\ 0\\.07971793204717322\ \(0\)\
\-\ that\\:\\ 0\\.07702102378994961\ \(0\)\
\-\ having\\:\\ 0\\.07650558151840108\ \(0\)\
\-\ focus\\:\\ 0\\.07517132544550814\ \(0\)\
\-\ and\\:\\ 0\\.07334943299640613\ \(0\)\
\-\ is\\:\\ 0\\.07290744265435217\ \(0\)\
\-\ atypical\\:\\ 0\\.07280370997715276\ \(0\)\
\-\ described\\:\\ 0\\.07200117633205678\ \(0\)\
\-\ linear\\:\\ 0\\.07148826880569954\ \(0\)\
\-\ condition\\:\\ 0\\.07091049682993533\ \(0\)\
\-\ hyperintense\\:\\ 0\\.07058972699603869\ \(0\)\
\-\ csf\\:\\ 0\\.07012064264067806\ \(0\)\
\-\ reports\\:\\ 0\\.06900631542480734\ \(0\)\
\-\ cells\\:\\ 0\\.06837412427565746\ \(0\)\
\-\ uptake\\:\\ 0\\.06823705919712775\ \(0\)\
\-\ complications\\:\\ 0\\.0679664995814627\ \(0\)\
\-\ rare\\:\\ 0\\.06699185194080357\ \(0\)\
\-\ 14\\:\\ 0\\.06625384230052422\ \(0\)\
\-\ radiographic\\:\\ 0\\.06583897009360695\ \(0\)\
\-\ cord\\:\\ 0\\.06578059559442909\ \(0\)\
\-\ activity\\:\\ 0\\.06515252995616688\ \(0\)\
\-\ early\\:\\ 0\\.06396770397910664\ \(0\)\
\-\ grade\\:\\ 0\\.06381290881360917\ \(0\)\
\-\ peripheral\\:\\ 0\\.06345759972976887\ \(0\)\
\-\ nerve\\:\\ 0\\.06330777398957398\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.06301238310642232\ \(0\)\
\-\ spinal\\:\\ 0\\.06301238310642232\ \(0\)\
\-\ typically\\:\\ 0\\.06229755050821031\ \(0\)\
\-\ effect\\:\\ 0\\.06225104289277291\ \(0\)\
\-\ new\\:\\ 0\\.061392831316636275\ \(0\)\
\-\ this\\:\\ 0\\.06098640067797525\ \(0\)\
\-\ thickening\\:\\ 0\\.060372348445421685\ \(0\)\
\-\ space\\:\\ 0\\.05907026073897503\ \(0\)\
\-\ radiation\\:\\ 0\\.05880753434894247\ \(0\)\
\-\ spine\\:\\ 0\\.058622552552573204\ \(0\)\
\-\ patient\\:\\ 0\\.057726353281334644\ \(0\)\
\-\ superior\\:\\ 0\\.057694579255916895\ \(0\)\
\-\ adjacent\\:\\ 0\\.057522298582960894\ \(0\)\
\-\ onset\\:\\ 0\\.05698348158108285\ \(0\)\
\-\ brain\\:\\ 0\\.05532125816555254\ \(0\)\
\-\ on\\:\\ 0\\.05360295258855711\ \(0\)\
\-\ abnormal\\:\\ 0\\.05331474484634928\ \(0\)\
\-\ focal\\:\\ 0\\.053081194051229415\ \(0\)\
\-\ been\\:\\ 0\\.051701841729266826\ \(0\)\
\-\ t2\\:\\ 0\\.05105547279168467\ \(0\)\
\-\ therapy\\:\\ 0\\.05098778543713934\ \(0\)\
\-\ lesions\\:\\ 0\\.05096528827374294\ \(0\)\
\-\ low\\:\\ 0\\.05092039131393001\ \(0\)\
\-\ consistent\\:\\ 0\\.048117714478839016\ \(0\)\
\-\ increased\\:\\ 0\\.047987219405169694\ \(0\)\
\-\ chest\\:\\ 0\\.046842295671767974\ \(0\)\
\-\ associated\\:\\ 0\\.04677346022416052\ \(0\)\
\-\ imaging\\:\\ 0\\.046636696391446235\ \(0\)\
\-\ case\\:\\ 0\\.04458279800403302\ \(0\)\
\-\ large\\:\\ 0\\.04446392991260379\ \(0\)\
\-\ have\\:\\ 0\\.04433128005916305\ \(0\)\
\-\ findings\\:\\ 0\\.04379752248950534\ \(0\)\
\-\ lesion\\:\\ 0\\.04254468107126679\ \(0\)\
\-\ as\\:\\ 0\\.03565063671720085\ \(0\)\
\-\ mass\\:\\ 0\\.03389690940985664\ \(0\)\
\-\ are\\:\\ 0\\.033673388527576335\ \(0\)\
\-\ no\\:\\ 0\\.02885774764540111\ \(0\)\
\-\ year\\:\\ 0\\.027348403609560704\ \(0\)\
\-\ old\\:\\ 0\\.026263934350023388\ \(0\)\
\-\ to\\:\\ 0\\.022185217298864364\ \(0\)\
